The need to manage the risk of thromboembolism in COVID-19 patients

COVID-19 first appeared in Wuhan, Hubei Province, China, in December 2019. Thought to be of zoonotic origin, it has been named SARS-CoV-2 (COVID-19) and has spread rapidly. As of April 20, 2020, there have been >2.4 million cases recorded worldwide. The inflammatory process, cytokine storm, and l...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Inayat Hussain, Savarimuthu, Sugeevan, Leung, Marco Shiu Tsun, Harky, Amer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the Society for Vascular Surgery. Published by Elsevier Inc. 2020
Materias:
COVID-19 and vascular disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224653/
https://www.ncbi.nlm.nih.gov/pubmed/32417304
http://dx.doi.org/10.1016/j.jvs.2020.05.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224653/
https://www.ncbi.nlm.nih.gov/pubmed/32417304
http://dx.doi.org/10.1016/j.jvs.2020.05.015

Ejemplares similares